跳至主要内容
临床试验/ACTRN12621001738819
ACTRN12621001738819招募中未知

A multicentre randomised controlled trial evaluating whether a computed tomography calcium score in women with non-traditional cardiovascular risk factors can detect premature atherosclerosis and be used to improve cardiovascular risk factor control

The University of Sydney0 个研究点目标入组 700 人开始时间: 2021年12月20日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
700

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
35 Years 至 65 Years(—)
性别
Female

入选标准

  • 1. Women able to give their informed consent will be eligible for inclusion if they are:
  • Criteria 1: Aged 40-65 years (35-65 years if Aboriginal and Torres Strait Islander)
  • Criteria 2: Low or intermediate risk for CVD based on traditional risk score (Australian absolute cardiovascular risk score between 3-15% inclusive)
  • Criteria 3: At least 1 risk-enhancing factor(s) (‘novel’ CVD risk factor) of:
  • a.Hypertensive disorder of pregnancy: gestational hypertension or pre-eclampsia and/or
  • b.Gestational diabetes and/or
  • c.Premature menopause (surgical/natural of age 44 years and less) and/or
  • d.Aboriginal and/or Torres Strait Islander background

排除标准

  • Very low risk for CVD (3% or below) or high risk for CVD (>15%) based on an Australian Absolute cardiovascular disease risk calculator: https://www.cvdcheck.org.au
  • Age 60 or over with diabetes mellitus (this automatically equates to risk score >15%)
  • Pre-existing cardiovascular disease (cardiac, cerebrovascular or peripheral vascular disease)
  • Known statin intolerance
  • On dialysis (as this can affect calcium scoring)
  • Currently pregnant or breastfeeding or plans for future pregnancies
  • Limited life expectancy of more than 5 years or diagnosis with a terminal illness
  • Unable to provide informed consent

研究者

相似试验

进行中(未招募)
1 期
A multicentre randomized controlled trial evaluating the rate of sustained remission and the safety when stopping nucleos(t)ide analogue treatment in non-cirrhotic HBeAg-negative chronic Hepatitis B patients with long-term virologic responseHBeAg negative chronic Hepatitis B virus (HBV) infectionMedDRA version: 20.1Level: PTClassification code 10008910Term: Chronic hepatitis BSystem Organ Class: 10021881 - Infections and infestations
EUCTR2013-004882-15-DEniversität Leipzig160
已完成
不适用
A multicentre randomized controlled trial evaluating the rate of sustained remission and the safety when stopping nucleos(t)ide analogue treatment in non-cirrhotic HBeAg-negative chronic Hepatitis B patients with long-term virologic responseMedDRA - chronic hepatitis BB18Chronic viral hepatitis
DRKS00006240niversität Leipzig166
进行中(未招募)
不适用
The Operative Rib Fixation (ORiF) studyRib fracturesInjury, Occupational Diseases, PoisoningFracture of rib
ISRCTN10777575ottingham University Hospitals NHS Trust467
已完成
不适用
A multicentre randomised controlled trial assessing the benefit of icodextrin solution on pelvic pain and quality of life in patients having surgery to adhesionsRespiratory: PainRespiratoryPain
ISRCTN77645288Department of Health (UK)250
尚未招募
不适用
A Multi-Centre randomised controlled trial: Evaluation of Ovarian reserve following surgical treatment of endometriomas by excision or ablation.Ovarian endometriosisReproductive Health and Childbirth - Other surgery
ACTRN12605000714684AGES42